We are live on ! Find out more
AC

Aisling Capital Portfolio holdings

AUM $45.3M
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+22.22%
1 Year Est. Return
-15.24%
3 Year Est. Return
+386.13%
5 Year Est. Return
+981.36%
10 Year Est. Return
–
AUM
$561M
AUM Growth
+$54.9M
Cap. Flow
-$18.9M
Cap. Flow %
-3.37%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$12.9M
2
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$4.95M

Sector Composition

Rank Sector Weight
1 Healthcare 77.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$397M 70.71%
3,438,920
– –
AIMT
2
DELISTED
Aimmune Therapeutics
AIMT
$71.3M 12.71%
2,240,000
– –
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
$48.1M 8.57%
7,480,887
– –
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$16.8M 3%
760,719
– –
ADMA icon
5
ADMA Biologics
ADMA
$1.94B
$16.6M 2.96%
3,608,171
– –
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
$4.08M 0.73%
51,057
– –
AGRX
7
DELISTED
Agile Therapeutics
AGRX
$3.35M 0.6%
652
– –
CMRX
8
DELISTED
Chimerix, Inc.
CMRX
$2.46M 0.44%
472,943
– –
PTX
9
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$502K 0.09%
210,000
– –
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-50,857
Closed -$4.95M
ENTL
11
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-528,655
Closed -$12.9M

Similar funds

SCPM
Sagard Capital Partners Management New York $46.7M AUM 23.43% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return
INL
IPC/NYCG LLC New York $43.3M AUM 61.41% 1-Year Est. Return
CP
Clover Partners Dallas, Texas $43.1M AUM 4.09% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
JCM
Julex Capital Management Wellesley, Massachusetts $42.4M AUM 9.78% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return

Aisling Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Aisling Capital held 12 positions worth $561M, up 11% from $506M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Aisling Capital withdrew a net $18.9M in Q1 2018, closing 2 positions. Its most notable exit was Entellus Medical, Inc. Common Stock, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 69% a quarter earlier.

  • Aisling Capital fully exited Entellus Medical, Inc. Common Stock in Q1 2018, selling an estimated $12.9M.
  • Aisling Capital's ten largest holdings make up 100% of its $561M portfolio in Q1 2018.
  • Aisling Capital opened 0 new positions and closed 2 in Q1 2018.
  • Aisling Capital's portfolio value rose 11% quarter-over-quarter to $561M.

Based on Aisling Capital's 13F filing for Q1 2018, filed 14 May 2018.